0001708138-20-000050.txt : 20200508
0001708138-20-000050.hdr.sgml : 20200508
20200508160306
ACCESSION NUMBER: 0001708138-20-000050
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20200507
FILED AS OF DATE: 20200508
DATE AS OF CHANGE: 20200508
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Zoghbi Huda Y
CENTRAL INDEX KEY: 0001681643
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-19034
FILM NUMBER: 20860469
MAIL ADDRESS:
STREET 1: REGENERON PHARMACEUTICALS, INC.
STREET 2: 777 OLD SAW MILL RIVER ROAD
CITY: TARRYTOWN
STATE: NY
ZIP: 10591
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: REGENERON PHARMACEUTICALS, INC.
CENTRAL INDEX KEY: 0000872589
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 133444607
STATE OF INCORPORATION: NY
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 777 OLD SAW MILL RIVER ROAD
CITY: TARRYTOWN
STATE: NY
ZIP: 10591
BUSINESS PHONE: 9148477000
MAIL ADDRESS:
STREET 1: 777 OLD SAW MILL RIVER ROAD
CITY: TARRYTOWN
STATE: NY
ZIP: 10591
FORMER COMPANY:
FORMER CONFORMED NAME: REGENERON PHARMACEUTICALS INC
DATE OF NAME CHANGE: 19930328
4
1
edgardoc.xml
PRIMARY DOCUMENT
X0306
4
2020-05-07
0
0000872589
REGENERON PHARMACEUTICALS, INC.
REGN
0001681643
Zoghbi Huda Y
777 OLD SAW MILL RIVER ROAD
TARRYTOWN
NY
10591
1
0
0
0
Common Stock
2020-05-07
4
M
0
5118
391.92
A
5761
D
Common Stock
2020-05-07
4
S
0
1722
565.64
D
4039
D
Common Stock
2020-05-07
4
S
0
2128
566.37
D
1911
D
Common Stock
2020-05-07
4
S
0
646
567.58
D
1265
D
Common Stock
2020-05-07
4
S
0
609
568.37
D
656
D
Common Stock
2020-05-07
4
S
0
13
569.2
D
643
D
Non-Qualified Stock Option (right to buy)
391.92
2020-05-07
4
M
0
5118
0.0
D
2026-09-09
Common Stock
5118
10235
D
Represents volume-weighted average price of sales of 1,722 shares of Company stock on May 7, 2020 at prices ranging from $565.43 to $565.98. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on May 7, 2020 at each separate price.
Represents volume-weighted average price of sales of 2,128 shares of Company stock on May 7, 2020 at prices ranging from $566.00 to $566.83. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on May 7, 2020 at each separate price.
Represents volume-weighted average price of sales of 646 shares of Company stock on May 7, 2020 at prices ranging from $567.20 to $567.97. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on May 7, 2020 at each separate price.
Represents volume-weighted average price of sales of 609 shares of Company stock on May 7, 2020 at prices ranging from $568.05 to $568.75. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on May 7, 2020 at each separate price.
The stock option becomes exercisable in three equal annual installments, commencing one year after the date of grant.
/s/**Huda Y. Zoghbi
2020-05-07